James Molloy's questions to Abeona Therapeutics Inc (ABEO) leadership • Q1 2025
Question
James Molloy from Alliance Global Partners inquired about the identity of the priority review voucher (PRV) buyer, sought clarification on whether the 2026 profitability target is based on EPS or cash flow, and asked if the stronger balance sheet has attracted acquisition interest.
Answer
CFO Joe Vazzano confirmed the PRV buyer is undisclosed and clarified that the 2026 profitability projection refers to positive EPS. CEO Dr. Vish Seshadri stated it was premature to comment on any potential inbound acquisition interest.